AbbVie discovers and delivers innovative medicines for complex health challenges. With a portfolio spanning immunology, oncology, neuroscience and aesthetics, the company treats over 75 conditions, serving around 60 million people annually across 175+ countries. Their work combines rigorous science with deep patient understanding, partnering with physicians, caregivers and communities to create meaningful solutions. Founded in 2013, AbbVie maintains a robust research pipeline whilst supporting patients beyond the medicine. From Parkinson's disease research to aesthetic medicine, their approach balances focused innovation with commercial scale, ensuring breakthroughs reach those who need them most.
57000
Team Members
2013
Founded
Pharma
Sector
Hybrid
Work Environment
A world where serious and complex health conditions no longer limit people's lives, and where scientific persistence unlocks answers that transform health outcomes for patients and communities globally.
At AbbVie, our mission is to discover and deliver innovative medicines and solutions that address complex health issues and enhance people's lives.